Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04671251 · COMPLETED
Trial details
- NCT number
- NCT04671251
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-03-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.